Back to Directory

Michael Whitton

Email

mwhitton@fhi360.org

Phone

919-321-3852

Institution

FHI 360

Title

Clinical Research Manager

Address

FHI 360
359 Blackwell St.
Suite 200
Durham, NC 27701
United States of America

Request an Update

Affiliated Studies

IMPAACT 2050: Phase IV Study of the Pharmacokinetics and Safety of Long-Acting Injectable Cabotegravir and Rilpivirine in Pregnant and Postpartum Women with HIV-1

DAIDS Number

IMPAACT 2049: LEAP

DAIDS Number

Research Area

Study Status

IMPAACT 2040: Phase I/II Study of the Pharmacokinetics and Safety of Long-Acting Injectable Cabotegravir and Rilpivirine in Pregnant and Postpartum Women with HIV-1

DAIDS Number

Research Area

Study Status

IMPAACT 2028: Long-Term Clinical, Immunologic, and Virologic Profiles of Children who Received Early Treatment for HIV

DAIDS Number

Research Area

Cure and Immunotherapy

Study Status

Closed to Accrual

IMPAACT 2017: MOCHA

DAIDS Number

Research Area

Study Status

Participants Off Study and Primary Analysis Completed

Show All